WX
Wuxi XDC
OrganizationHeard in 1 episode across 1 show since Aug 2026
A China-based contract research, development, and manufacturing organization specializing in antibody-drug conjugates (ADCs) and related bioconjugate medicines; it is not primarily a generic-drug maker.
Episodes
1
across 1 show
First heard
Aug 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 1 |
| Sep 2026 | 0 |
| Oct 2026 | 0 |
What experts have said about Wuxi XDC
1 statement · 1 positive
Wuxi XDC reported exceptionally strong quarterly earnings and rose about 10%.
“They had a blowout earnings quarter. It was up around 10%.”
Open the episode · MUFJ Rises, Xpeng Drops, WuXi XDC JumpsListen at 2:17
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Wuxi XDC, newest first
